Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc.verified

ELTP

Price:

$0.52

Market Cap:

$555.69M

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsul...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-02-24

Stock Exchange

OTC

Ticker

ELTP

The ROE as of December 2025 (TTM) for Elite Pharmaceuticals, Inc. (ELTP) is 27.95%

According to Elite Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 27.95%. This represents a change of 848.80% compared to the average of 2.95% of the last 4 quarters.

Elite Pharmaceuticals, Inc. (ELTP) Historical ROE (quarterly & annually)

How has ELTP ROE performed in the past?

The mean historical ROE of Elite Pharmaceuticals, Inc. over the last ten years is 1.52%. The current 27.95% ROE has changed -98.16% with respect to the historical average. Over the past ten years (40 quarters), ELTP's ROE was at its highest in in the December 2015 quarter at 591.20%. The ROE was at its lowest in in the December 2024 quarter at -29.89%.

Quarterly (TTM)
Annual

Average

1.52%

Median

4.37%

Minimum

-81.43%

Maximum

15.23%

Elite Pharmaceuticals, Inc. (ELTP) ROE by Quarter and Year

Discovering the peaks and valleys of Elite Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 43.06%

Maximum Annual ROE = 15.23%

Minimum Annual Increase = -342.72%

Minimum Annual ROE = -81.43%

Quarterly (TTM)
Annual
YearROEChange
2025-8.06%-123.09%
202434.92%-99.77%
202315.23%43.06%
202235.28%11.99%
202131.50%-249.84%
2020-21.02%-74.18%
2019-81.43%309.56%
2018-19.88%-233.88%
201714.85%-342.72%
2016-6.12%-92.65%

Elite Pharmaceuticals, Inc. (ELTP) Average ROE

How has ELTP ROE performed in the past?

The current ROE of Elite Pharmaceuticals, Inc. (ELTP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.08%

5-year avg

3.06%

10-year avg

1.52%

Elite Pharmaceuticals, Inc. (ELTP) ROE vs. Peers

How is ELTP’s ROE compared to its peers?

Elite Pharmaceuticals, Inc.’s ROE is less than YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (5.62%), less than AB Science S.A. (32.39%), less than Torii Pharmaceutical Co., Ltd. (4.46%), less than Swedencare AB (publ) (0.87%), less than Glass House Brands Inc. (6.09%), less than ManifestSeven Holdings Corporation (1.66%), less than Boiron S.A. (5.18%), less than Allergy Therapeutics plc (2.07%), less than Avisa Diagnostics Inc. (408.59%), less than Basilea Pharmaceutica AG (70.33%),

Build a custom stock screener for Elite Pharmaceuticals, Inc. (ELTP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Elite Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Elite Pharmaceuticals, Inc. (ELTP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Elite Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Elite Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Elite Pharmaceuticals, Inc. (ELTP)?

What is the highest ROE for Elite Pharmaceuticals, Inc. (ELTP)?

What is the 3-year average ROE for Elite Pharmaceuticals, Inc. (ELTP)?

What is the 5-year average ROE for Elite Pharmaceuticals, Inc. (ELTP)?

How does the current ROE for Elite Pharmaceuticals, Inc. (ELTP) compare to its historical average?